文献速递冠心病心力衰竭与心肌病

心源性休克严重程度分期的定义标准

Criteria for Defining Stages of Cardiogenic Shock Severity.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

本研究基于心源性休克工作组注册研究(17家医院,2016-2021年,3455例患者),测试了定义SCAI分期的参数,并探索其作为院内死亡预测指标的价值。研究确认收缩压、乳酸水平、丙氨酸转氨酶和系统pH与死亡率显著相关,并据此定义了各分期的正式标准。基线和最高分期均与死亡率显著相关,较低基线分期与分期升级发生率较高和达到最高分期时间较短相关。

要点

  • 基于收缩压、乳酸、ALT和pH定义SCAI分期标准。
  • 基线和最高SCAI分期均与院内死亡率显著相关。
  • 较低基线分期者更易发生分期升级且进展更快。

核心结论

  • 提出了一种定义SCAI分期的全新方法,并发现基线和最高分期与死亡率显著相关。

研究设计与样本

  • 回顾性注册研究,纳入17家医院2016至2021年间收治的3455例心源性休克患者。

主要发现

  • 总队列死亡率为35%,心肌梗死、院外心脏骤停及使用更多药物和设备的患者死亡率更高。
  • 收缩压、乳酸水平、丙氨酸转氨酶水平和系统pH与死亡率显著相关,并用于定义各分期。
  • 在1890例患者中,基线和最高分期均与死亡率显著相关。
  • 较低基线分期与分期升级发生率较高及达到最高分期时间较短相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk-stratifying patients with cardiogenic shock (CS) is a major unmet need. The recently proposed Society for Cardiovascular Angiography and Interventions (SCAI) staging system for CS severity lacks uniform criteria defining each stage. OBJECTIVES: The purpose of this study was to test parameters that define SCAI stages and explore their utility as predictors of in-hospital mortality in CS. METHODS: The CS Working Group registry includes patients from 17 hospitals enrolled between 2016 and 2021 and was used to define clinical profiles for CS. We selected parameters of hypotension and hypoperfusion and treatment intensity, confirmed their association with mortality, then defined formal criteria for each stage and tested the association between both baseline and maximum Stage and mortality. RESULTS: Of 3,455 patients, CS was caused by heart failure (52%) or myocardial infarction (32%). Mortality was 35% for the total cohort and higher among patients with myocardial infarction, out-of-hospital cardiac arrest, and treatment with increasing numbers of drugs and devices. Systolic blood pressure, lactate level, alanine transaminase level, and systemic pH were significantly associated with mortality and used to define each stage. Using these criteria, baseline and maximum stages were significantly associated with mortality (n = 1,890). Lower baseline stage was associated with a higher incidence of stage escalation and a shorter duration of time to reach maximum stage. CONCLUSIONS: We report a novel approach to define SCAI stages and identify a significant association between baseline and maximum stage and mortality. This approach may improve clinical application of the staging system and provides new insight into the trajectory of hospitalized CS patients. (Cardiogenic Shock Working Group Registry [CSWG]; NCT04682483).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Kapur, Kanwar, Sinha, et al. Criteria for Defining Stages of Cardiogenic Shock Severity. J Am Coll Cardiol. 2022. PMID: 35835491. doi:10.1016/j.jacc.2022.04.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。